While Medtronic has sought prospective buyers for the unit, arrangements are still in early stages, the source said.
The medical supply unit, which sells everything from needles to monitoring equipment, could be valued at up to $5 billion. The sale would mainly offload assets Medtronic gained through its $42.9 billion acquisition of Covidien in 2014, according to the report.
It’s unknown whether Medtronic will sell the medical supplies unit as a whole or split the unit into smaller divestitures, reports Bloomberg.
A Medtronic spokesman told Becker’s the company does not comment on rumors of divestitures.
More articles on supply chain:
Shifting drug production back to US could raise prices: 5 takeaways
5 ways to prepare your supply chain for a disaster
Mayo Clinic physician: A stripped down FDA would be ‘chaotic’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
